{
    "organizations": [],
    "uuid": "27524e0bf32c07924419136fc2eb12dc5539e74c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cocrystal-pharma-receives-fda-clea/brief-cocrystal-pharma-receives-fda-clearance-to-initiate-phase-2a-clinical-study-evaluating-cc-31244-for-treatment-of-hepatitis-c-virus-idUSFWN1RG0JZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Cocrystal Pharma Receives FDA Clearance To Initiate Phase 2A Clinical Study Evaluating CC 31244 For Treatment Of Hepatitis C Virus",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Cocrystal Pharma Inc:\n* 31244 * 31244 WITH APPROVED HCV DRUGS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T20:11:00.000+03:00",
    "crawled": "2018-04-04T12:41:19.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "cocrystal",
        "pharma",
        "inc",
        "approved",
        "hcv",
        "drug",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}